Deep Genomics has offices in Toronto and Boston. The AI platform and preclinical research teams are located in the heart of Toronto, the fastest growing tech hub in North America and widely recognized as one of the most livable cities in the world. The facilities are located in the MaRS Discovery District, right beside the University of Toronto, four research hospitals, three medical research institutes, and the AI research labs of Google, Uber and the Vector Institute for Artificial Intelligence. The clinical development and business development teams are led out of Boston.
Deep Genomics has over 100 team members, with expertise in artificial intelligence, automation, cell and molecular biology, clinical development, in vitro disease models, machine learning, medicine, molecular genetics, preclinical development, organic chemistry, and software engineering.
Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI. The company use its AI Workbench to rapidly discover and develop genetic medicines, and to do so with a high rate of success.
Deep Genomics' AI Workbench untangles the complexity in RNA biology, identifies novel targets, and evaluates thousands of possibilities to identify the best therapeutic candidates. Through iteration and positive feedback loops, prediction with Deep Genomics' AI Workbench improves and unlocks new therapeutic opportunities. AI Workbench 1.0 focused on correcting RNA splicing as a means to restore protein expression.
Deep Genomics Introduction